Teradyne price target raised to $397 from $387 at Morgan Stanley
Bullish upgrade; valuation supports further gains.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish upgrade; valuation supports further gains.
What happened, with direct paths to the underlying reporting
TER target raised to $397 from $387 by Morgan Stanley; current price about $361.79.
Target: $397
Posted price: $361.79
Analyst firm: Morgan Stanley
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.